Eli LIlly

SPHP’s Monoclonal Antibody Program Recognized by Duke University for Best Practices

February 18, 2021

The Duke Margolis Center for Health Policy has highlighted St. Peter's Health Partners in its new report “Promising Practices for Promoting Utilization of COVID-19 Monoclonal Antibody Treatments.” [...]

WTEN: New COVID Antibody Treatment Found Highly Effective in Preventing Hospitalizations

February 16, 2021

Melissa Fiorini, M.D., clinical director of St. Peter's Health Partners' monoclonal antibody infusion clinic, was interviewed by WTEN/News10 about the COVID-19 treatment, including a new antibody recently approved by the FDA. [...]

St. Peter’s Health Partners Expanding Monoclonal Antibody Therapy for COVID-19 Patients

February 3, 2021

St. Peter's Health Partners continues to be at the forefront of treating COVID-19 patients with the most cutting-edge therapies available, including monoclonal antibody therapy. SPHP's monoclonal antibody infusion clinic, located on the Albany Memorial Campus has treated more than 450 patients since opening on Dec. 3rd. [...]